Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  BioPorto A/S    BIOPOR   DK0011048619

BIOPORTO A/S (BIOPOR)

Delayed Quote. Delayed  - 05/29 04:59:55 pm
2.6 DKK   -2.99%
05/04 BIOPORTO A/S : Interim report, first quarter of 2017
05/01 BIOPORTO A/S : Invitation to investor meeting in Århus
04/21 BIOPORTO A/S : Annual General Meeting
 SummaryQuotesChartsNewsCalendarCompany 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Copenhagen
05/19/2017 05/22/2017 05/23/2017 05/24/2017 05/29/2017 Date
2.57(c) 2.6(c) 2.69(c) 2.68(c) 2.6(c) Last
764 719 922 892 670 422 339 269 480 523 Volume
+7.53% +1.17% +3.46% -0.37% -2.99% Change
More quotes
Company
BioPorto A/S is an in-vitro diagnostics company.It provides healthcare professionals in clinical and research settings a range of diagnostic tests and antibodies.The company focuses on the diagnosis of obesity, diabetes, primary immune deficiency, and kidney injury.Its products include The NGAL... 
Sector
Pharmaceuticals
Calendar
08/10Earnings Release
More about the company
Latest news on BIOPORTO A/S
05/04 BIOPORTO A/S : Interim report, first quarter of 2017
05/01 BIOPORTO A/S : Invitation to investor meeting in Århus
04/21 BIOPORTO A/S : Annual General Meeting
04/13 BIOPORTO A/S : First patient recruited for The NGAL Test clinical study in the U..
04/12 BIOPORTO A/S : First patient recruited for The NGAL Test™ clinical study i..
04/03 BIOPORTO A/S : Grant of Warrants to Employees and adjustment of EBIT forecast fo..
03/17 BIOPORTO A/S : Notice Convening the Annual General Meeting
03/15 BIOPORTO A/S : Comeback with a view to growth.
02/09 BIOPORTO A/S : Announcement from major shareholder
02/03 BIOPORTO A/S : Siemens cooperation enters into the next phase.
More news
Sector news : Diagnostic & Testing Substances Manufacturers
05/29 WARREN BUFFETT : Warren Buffett takes 3 percent stake in Germany's Lanxess
05/29DJMERCK : Congo Approves Anti-Ebola Vaccine to Combat Outbreak in Remote Northeast
05/26DJSUN PHARMACEUTICAL INDUSTRIES : Pharma 4Q Profit Falls 13.6%
05/24 JOHNSON & JOHNSON : J&J settles drug manufacturing probe by U.S. states for $33 ..
05/24 FTSE edges up helped by M&S, but miners weigh
More sector news : Diagnostic & Testing Substances Manufacturers
Latest Tweets
04/12BioPorto Release: First Patient Recruited For The NGAL Test Clinical Study In.. 
04/12BioPorto A/S : First patient recruited for The NGAL Test™ clinical .. 
01/30BioPorto A/S: BioPorto completes pre-submission discussions with the FDA #Fin.. 
2016BioPorto A/S: BioPorto expands its NGAL related patent portfolio #Finanzierun.. 
More tweets
Qtime:2
Advertisement
Chart BIOPORTO A/S
Duration : Period :
BioPorto A/S Technical Analysis Chart | BIOPOR | DK0011048619 | 4-Traders
Full-screen chart
Technical analysis trends BIOPORTO A/S
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Managers
NameTitle
Peter Mørch Eriksen CEO & Investor Relations Contact
Thomas Magnussen Chairman
Jan Kuhlmann Andersen Chief Operating Officer
Jakob Brix Christensen Chief Financial Officer
Torben A. Nielsen Vice Chairman
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BIOPORTO A/S27.62%0
JOHNSON & JOHNSON10.16%341 901
ROCHE HOLDING LTD.14.62%236 581
NOVARTIS AG6.07%211 457
PFIZER INC.-1.05%191 398
MERCK & CO., INC.10.28%177 567
More Results